Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Modeling to design optimized estrogen-specific muscle regeneration treatment

Award Number: R21AR080415
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2022
PERIOD OF PERFORMANCE END DATE: 12/31/2024

Group Awards By:

View Award Description

Modeling to design optimized estrogen-specific muscle regeneration treatment - SUMMARY The goal of this proposal is to develop an estrogen-specific muscle regeneration agent-based model (ABM) and use it to conduct in silico experiments to identify the optimal set of growth factor interventions that improve muscle regeneration following injury. This new model will allow the field to understand how sex differences play a role in the treatment of muscle injury. It is known that current muscle injury treatments cleared by the FDA have sex- differences, which can be attributed to differences in sex hormones. Likewise, it is well documented that estrogen has a multi-faceted impact on muscle regeneration. However, while muscle regeneration models have been developed, they are based on male-only data and do not offer any insight into how sex differences alter muscle injury outcomes. These profound limitations leave the field without any tools to examine how differences in sex hormones may influence muscle damage, regeneration, and treatment outcomes. This project has two key aims that will resolve these profound limitations. The first aim will develop and validate a muscle regeneration ABM that accounts for the role of estrogen through the use of coupled in vivo and in silico experiments. This aim will be achieved by collecting data from freeze injured female mice that are receiving specified amounts of estrogen and using different subsets of the data to tune and validate the ABM. The second aim will simulate combinations of growth factors at varying levels of estrogen to identify how treatment procedures could be optimized by timing the dosage of growth factors according to estrogen levels during the menstrual cycle. Reinforcement machine learning will be used to identify the combination of growth factors, dosages, and timing that would lead to the fastest muscle recovery at varying levels of estrogen. These model-predicted optimal treatments for each estrogen level will be experimentally tested in vivo. Taken together, these aims will develop the first computational model that incorporates the effects of estrogen levels to study how they impact muscle injury treatments. This work will provide an important new understanding of sex-based differences in muscle damage, inflammation, satellite stem cell response, and overall muscle regeneration outcomes that will be crucial to developing treatments that account for these differences.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$97 )
2025	2023	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 EMMET ST N	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	4/28/2025	NON-COMPETING CONTINUATION	-$97
														Subtotal = -$97

Issue Date FY: 2023 ( Subtotal = $166,526 )
2023	2023	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	1/9/2023	NON-COMPETING CONTINUATION	$149,873
2023	2023	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	4/24/2023	NON-COMPETING CONTINUATION	$16,653
														Subtotal = $166,526

Issue Date FY: 2022 ( Subtotal = $202,432 )
2022	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	1/28/2022	NEW	$202,432
														Subtotal = $202,432

Grand Total All Awards = $368,861

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Modeling to design optimized estrogen-specific muscle regeneration treatment

Award Number: R21AR080415

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2022

PERIOD OF PERFORMANCE END DATE: 12/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer